Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Endokrynologia Polska
MENU
Shortcuts Submit an article Author Guidelines Polish Society of Endocrinology Reviewers 2022 Redeem voucher Abstracts, 5–7 May 2022, Gliwice

open access

Vol 69, No 3 (2018)
Review paper
Submitted: 2018-02-26
Accepted: 2018-03-26
Published online: 2018-06-25
View PDF Download PDF file
Get Citation

Cystic pancreatic neuroendocrine tumours — a gastroenterologist’s point of view

Krzysztof Dąbkowski1, Beata Kos-Kudła2, Elżbieta Andrysiak-Mamos3, Anhelli Syrenicz3, Joanna Pilch-Kowalczyk4, Teresa Starzyńska1
DOI: 10.5603/EP.2018.0034
·
Pubmed: 29952422
·
Endokrynol Pol 2018;69(3):320-325.
Affiliations
  1. Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland, Poland
  2. Department of Endocrinology and Neuroendocrine tumors, Medical University of Silesia, Katowice, Poland
  3. Department of Endocrinology, Metabolic Diseases and Internal Medicine, Pomeranian Medical University in Szczecin, Poland
  4. Department of Nuclear Medicine and Diagnostic Imaging, Medical University of Silesia, Katowice, Poland.

open access

Vol 69, No 3 (2018)
Reviews — Postgraduate Education
Submitted: 2018-02-26
Accepted: 2018-03-26
Published online: 2018-06-25

Abstract

Cystic pancreatic tumors are detected with increasing frequency and remain a clinical problem. Since they have different potential of malignancy the management and decision making process is a hard task. Guidelines, concerning pancreatic cystic tumors indicate the management with mucinous, serous cystic pancreatic neoplasms and solid pseudopappilary tumor, while the management with pancreatic cystic neuroendocrine tumors is not included into these standards. This review tries to answer the question are the cystic pancreatic neuroendocrine tumors different entity from solid tumors of neuroendocrine origin.The management and differential diagnosis of these neoplasms with special focus on features on imaging studies allowing preoperative diagnosis are discussed.

Abstract

Cystic pancreatic tumors are detected with increasing frequency and remain a clinical problem. Since they have different potential of malignancy the management and decision making process is a hard task. Guidelines, concerning pancreatic cystic tumors indicate the management with mucinous, serous cystic pancreatic neoplasms and solid pseudopappilary tumor, while the management with pancreatic cystic neuroendocrine tumors is not included into these standards. This review tries to answer the question are the cystic pancreatic neuroendocrine tumors different entity from solid tumors of neuroendocrine origin.The management and differential diagnosis of these neoplasms with special focus on features on imaging studies allowing preoperative diagnosis are discussed.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

neuroendocrine pancreatic tumors, pancreatic cysts, EUS

About this article
Title

Cystic pancreatic neuroendocrine tumours — a gastroenterologist’s point of view

Journal

Endokrynologia Polska

Issue

Vol 69, No 3 (2018)

Article type

Review paper

Pages

320-325

Published online

2018-06-25

Page views

2718

Article views/downloads

1752

DOI

10.5603/EP.2018.0034

Pubmed

29952422

Bibliographic record

Endokrynol Pol 2018;69(3):320-325.

Keywords

neuroendocrine pancreatic tumors
pancreatic cysts
EUS

Authors

Krzysztof Dąbkowski
Beata Kos-Kudła
Elżbieta Andrysiak-Mamos
Anhelli Syrenicz
Joanna Pilch-Kowalczyk
Teresa Starzyńska

References (39)
  1. Kapoor VK. Complications of pancreato-duodenectomy. Rozhl Chir. 2016; 95(2): 53–59.
    PubMed
  2. He J, Ahuja N, Makary MA, et al. 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford). 2014; 16(1): 83–90.
    CrossRefPubMed
  3. Cameron JL, He J. Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg. 2015; 220(4): 530–536.
    CrossRefPubMed
  4. Tanaka M, Fernández-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017; 17(5): 738–753.
    CrossRefPubMed
  5. Del Chiaro M, Verbeke C, Salvia R, et al. European Study Group on Cystic Tumours of the Pancreas. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis. 2013; 45(9): 703–711.
    CrossRefPubMed
  6. Singhi AD, Chu LC, Tatsas AD, et al. Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. Am J Surg Pathol. 2012; 36(11): 1666–1673.
    CrossRefPubMed
  7. Kos-Kudła B, Rosiek V, Borowska M, et al. Pancreatic neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol. 2017; 68(2): 169–197.
    CrossRefPubMed
  8. Falconi M, Eriksson B, Kaltsas G, et al. Vienna Consensus Conference participants. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2016; 103(2): 153–171.
    CrossRefPubMed
  9. Kos-Kudła B, Blicharz-Dorniak J, Strzelczyk J, et al. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol. 2017; 68(2): 79–110.
    CrossRefPubMed
  10. Zhang XM, Mitchell DG, Dohke M, et al. Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology. 2002; 223(2): 547–553.
    CrossRefPubMed
  11. Spinelli K, Fromwiller T, Daniel R, et al. Cystic pancreatic neoplasms: observe or operate. Ann Surg. 2004; 239(5): 651–659.
    CrossRefPubMed
  12. Laffan TA, Horton KM, Klein AP, et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol. 2008; 191(3): 802–807.
    CrossRefPubMed
  13. Kimura W, Nagai H, Kuroda A, et al. Analysis of small cystic lesions of the pancreas. Int J Pancreatol. 1995; 18(3): 197–206.
    CrossRefPubMed
  14. Dabkowski K, Kojder K, Smereczyński A, et al. [Rare solid pancreatic tumors]. Pol Merkur Lekarski. 2013; 35(206): 111–118.
    PubMed
  15. Dabkowski K, Kojder K, Smereczyński A, et al. [Rare solid pancreatic tumors]. Pol Merkur Lekarski. 2013; 35(206): 111–118.
    PubMed
  16. Caglià P, Cannizzaro MT, Tracia A, et al. Cystic pancreatic neuroendocrine tumors: To date a diagnostic challenge. Int J Surg. 2015; 21 Suppl 1: S44–S49.
    CrossRefPubMed
  17. Koh YX, Chok AY, Zheng HL, et al. A systematic review and meta-analysis of the clinicopathologic characteristics of cystic versus solid pancreatic neuroendocrine neoplasms. Surgery. 2014; 156(1): 83–96.e2.
    CrossRefPubMed
  18. Bordeianou L, Vagefi PA, Sahani D, et al. Cystic pancreatic endocrine neoplasms: a distinct tumor type? J Am Coll Surg. 2008; 206(6): 1154–1158.
    CrossRefPubMed
  19. Morales-Oyarvide V, Yoon WJ, Ingkakul T, et al. Cystic pancreatic neuroendocrine tumors: the value of cytology in preoperative diagnosis. Cancer Cytopathol. 2014; 122(6): 435–444.
    CrossRefPubMed
  20. Gaujoux S, Tang L, Klimstra D, et al. The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis. Surgery. 2012; 151(4): 518–525.
    CrossRefPubMed
  21. Sureka B, Bihari C, Arora A, et al. Imaging paradigm of cystic lesions in pancreas. JOP Journal of the Pancreas. 2016; 17(5).
  22. Hurtado-Pardo L, A Cienfuegos J, Ruiz-Canela M, et al. Cystic pancreatic neuroendocrine tumors (cPNETs): a systematic review and meta-analysis of case series. Rev Esp Enferm Dig. 2017; 109(11): 778–787.
    CrossRefPubMed
  23. Buetow PC, Miller DL, Parrino TV, et al. Islet cell tumors of the pancreas: clinical, radiologic, and pathologic correlation in diagnosis and localization. Radiographics. 1997; 17(2): 453–72; quiz 472A.
    CrossRefPubMed
  24. Cloyd JM, Kopecky KE, Norton JA, et al. Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis. Surgery. 2016; 160(3): 708–713.
    CrossRefPubMed
  25. Paiella S, Marchegiani G, Miotto M, et al. Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity Results from a Single-Center Surgical Series. Neuroendocrinology. 2018; 106(3): 234–241.
    CrossRefPubMed
  26. Yoon WJ, Daglilar ES, Pitman MB, et al. Cystic pancreatic neuroendocrine tumors: endoscopic ultrasound and fine-needle aspiration characteristics. Endoscopy. 2013; 45(3): 189–194.
    CrossRefPubMed
  27. Koniusz J, Dąbkowski K, Buczek K, et al. [Gastroenterological manifestations of von Hippel-Lindau disease]. Pol Merkur Lekarski. 2017; 43(254): 53–55.
    PubMed
  28. Dumonceau JM, Deprez PH, Jenssen C, et al. Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated January 2017. Endoscopy. 2017; 49(7): 695–714.
    CrossRefPubMed
  29. de Jong K, Poley JW, van Hooft JE, et al. Endoscopic ultrasound-guided fine-needle aspiration of pancreatic cystic lesions provides inadequate material for cytology and laboratory analysis: initial results from a prospective study. Endoscopy. 2011; 43(7): 585–590.
    CrossRefPubMed
  30. Thosani N, Thosani S, Qiao W, et al. Role of EUS-FNA-based cytology in the diagnosis of mucinous pancreatic cystic lesions: a systematic review and meta-analysis. Dig Dis Sci. 2010; 55(10): 2756–2766.
    CrossRefPubMed
  31. Giuliano K, Ejaz A, He J. Technical aspects of pancreaticoduodenectomy and their outcomes. Chin Clin Oncol. 2017; 6(6): 64.
    CrossRefPubMed
  32. Kawamoto S, Johnson PT, Shi C, et al. Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT. AJR Am J Roentgenol. 2013; 200(3): W283–W290.
    CrossRefPubMed
  33. Ahrendt SA, Komorowski RA, Demeure MJ, et al. Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible? J Gastrointest Surg. 2002; 6(1): 66–74.
    PubMed
  34. Khashab MA, Kim K, Lennon AM, et al. Should we do EUS/FNA on patients with pancreatic cysts? The incremental diagnostic yield of EUS over CT/MRI for prediction of cystic neoplasms. Pancreas. 2013; 42(4): 717–721.
    CrossRefPubMed
  35. Kongkam P, Al-Haddad M, Attasaranya S, et al. EUS and clinical characteristics of cystic pancreatic neuroendocrine tumors. Endoscopy. 2008; 40(7): 602–605.
    CrossRefPubMed
  36. Lakhtakia S. Complications of diagnostic and therapeutic Endoscopic Ultrasound. Best Pract Res Clin Gastroenterol. 2016; 30(5): 807–823.
    CrossRefPubMed
  37. Kishida Y, Matsubayashi H, Okamura Y, et al. A case of solid-type serous cystadenoma mimicking neuroendocrine tumor of the pancreas. J Dig Dis. 2014; 15(4): 211–215.
    CrossRefPubMed
  38. Oruç N, Aydın A, Barutcuoğlu B, et al. Cystic fluid chromogranin A levels in different pancreatic cystic lesions. Turk J Gastroenterol. 2015; 26(6): 522–527.
    CrossRefPubMed
  39. Dabkowski K, Lubikowski J, Głuszko R, et al. [Pancreatic solid pseudopapillary tumor — report of three cases]. Pol Merkur Lekarski. 2014; 36(214): 265–269.
    PubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl